Aeterna Zentaris to Announce Second Quarter 2017 Financial and Operating Results on August 10, 2017
August 04 2017 - 4:00PM
Business Wire
Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the
“Company”) will announce its second quarter 2017 financial and
operating results after market close on Thursday, August 10, 2017.
The Company will host a conference call to discuss these results on
Friday, August 11, 2017 at 8:30 a.m. Eastern Time.
Participants may access the conference call using the following
number: 201-689-8029, Confirmation #13665527. A replay of the
conference call will also be available on the Company’s website for
a period of 30 days.
About Aeterna Zentaris Inc.
Aeterna Zentaris is a specialty biopharmaceutical company
engaged in developing and commercializing novel pharmaceutical
therapies. We are engaged in drug development activities and in the
promotion of products for others. We recently resubmitted an NDA to
the FDA seeking approval of MacrilenTM, an internally developed
compound. The focus of our business development efforts is the
acquisition of licenses to products that are relevant to our
therapeutic areas of focus. We also intend to license out certain
commercial rights of internally developed products to licensees in
non-U.S. territories where such out-licensing would enable us to
ensure development, registration and launch of our product
candidates. Our goal is to become a growth-oriented specialty
biopharmaceutical company by pursuing successful development and
commercialization of our product portfolio, achieving successful
commercial presence and growth, while consistently delivering value
to our shareholders, employees and the medical providers and
patients who will benefit from our products. For more information,
visit www.aezsinc.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170804005689/en/
Aeterna Zentaris Inc.Michael V. Ward, 843-900-3223Chief
Executive OfficerIR@aezsinc.com
Aeterna Zentaris (TSX:AEZS)
Historical Stock Chart
From Apr 2024 to May 2024
Aeterna Zentaris (TSX:AEZS)
Historical Stock Chart
From May 2023 to May 2024